Top Medical News
In a clinical practical setting, it is feasible to conduct a combined whole body and dedicated prostate magnetic resonance imaging (MRI), which can provide incremental information compared to standard imaging in men with suspected prostate cancer recurrence after radical prostatectomy, reports a study.
Gender, scale of the haematuria and socioeconomic status are all factors that affect the quality of haematuria assessment, a new systematic review reports.
5 days ago
Both 2 and 4 percent topical diazepam creams result in substantial improvements in pain and bleeding in chronic anal fissures, a new study shows.
9 days ago
Functional impairment, intellectual disability and fluid intake are important risk factors for urinary incontinence in children with cerebral palsy (CP), a study has found.
9 days ago
Obesity is associated with greater risk for unfavourable pathological features in men with low risk prostate cancer who are eligible for active surveillance, according to a study. Obese men are likely to have transition zone cancer, which is related to unfavourable pathology findings in those with very low risk prostate cancer.
11 days ago
Uric acid (UA) may play a protective role in the development of erectile dysfunction (ED), a recent study suggests.
12 days ago
The intravesical installation of Bacillus Calmette-Guerin (BCG) and mitomycin C (MMC) is a safe and effective approach to nonmuscle-invasive bladder cancer (NMIBC) following transurethral resection (TUR), a new systematic review shows.
Special Reports
15 Jun 2017
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).
Prof Choosak Pripatnanont, 23 Feb 2017
Experience-sharing interview: Managing a complicated case of lower urinary tract symptoms
Dr Colin Teo, 10 Dec 2016

Tolterodine: Experience-sharing interview with Dr Colin Teo

Professor Anthony Chi-Fai Ng, 30 Sep 2016


Experience-sharing interview with Professor Anthony Chi-Fai Ng

Professor Steven A Kaplan, 08 Aug 2016
Recently, at a Pfizer-sponsored continuing medical education event, Dr Steven Kaplan updated Malaysian healthcare professionals on some of the recent clinical advances in the management of male lower urinary tract symptoms (LUTS).
Professor John Mulhall, 06 Aug 2016
In the practice of sexual medicine, the goal of the treating physician is to help the patient (or the couple) return to satisfactory sexual relations. Healthy sexual activity is important, and many, including the elderly population, report of regular sexual activity.1,2 Erectile dysfunction is an important aspect of sexual health that often goes undetected. Crucial barriers to ED discussion in the clinic are patients’ embarrassment or reluctance to discuss the condition and the lack of knowledge or training on the physicians’ side.3
Roshini Claire Anthony, 25 Apr 2016

Elderly patients on androgen deprivation therapy (ADT) as part of prostate cancer treatment may be at an increased risk of depression, a recent study states.

Conference Reports
Jackey Suen, 24 Feb 2017

Research on the role of circulating tumour DNA (ctDNA) in metastatic castration-resistant prostate cancer (mCRPC) gains momentum, as a new study finds ctDNA assessment promising in the monitoring and prognosis of mCRPC and in identifying new therapeutic targets for the disease.

Dr. Joseph Delano Fule Robles, 22 Feb 2017

A recent study presented at the ASCO Genitourinary Cancers Symposium 2017 held in Orlando, Florida, US showed that antibiotic use in patients with metastatic renal cell carcinoma (mRCC) may dampen the efficacy of PD-1/PD-L1 inhibitors.

Christina Lau, 21 Feb 2017

Patients with castration-resistant prostate cancer (CRPC) may be able to reduce treatment cost by taking low-dose abiraterone acetate with a low-fat breakfast as a study shows noninferiority of the regimen compared with standard dosing on an empty stomach.

Roshini Claire Anthony, 03 Aug 2016

A combination of chemotherapy and androgen deprivation therapy (ADT) is recommended for men with extensive hormone-sensitive prostate cancer, according to a presentation at the 14th Urological Association of Asia (UAA) Congress 2016 held in Singapore. 

Pearl Toh, 03 Aug 2016
Testosterone replacement therapy (TRT) in hypogonadal men was associated with a lower cardiovascular (CV) risk, according to a presentation at the recent Urological Association of Asia Annual Congress (UAA 2016) held in Singapore, allaying concerns about the safety of TRT amidst controversial findings from previous studies.
Elvira Manzano, 03 Aug 2016
Family physicians or GPs, as referred to in many Asian countries, are well positioned to diagnose and treat uncomplicated benign prostatic hyperplasia (BPH), according to a leading urologist. Careful selection of patients is nonetheless crucial when starting therapy.
Jairia Dela Cruz, 02 Aug 2016
The best approach to management of genital infections, including acute bacterial prostatitis (ABP) and epididymitis, is to tailor therapy according to drug resistance patterns in patients, according to an expert who presented the UAA/AAUS* guidelines for genitourinary tract infection at the 14th Urological Association of Asia (UAA) Congress 2016 in Singapore.